Pauline Corbaux

9PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectives.

Pauline Corbaux, Gilles Freyer

|Feb 26, 2025
Cutaneous Anguillulosis During Immunotherapy for Metastatic Renal Cell Carcinoma.

Pierre Cornillon, Marie Beguinot, Denis Maillet

|Jun 17, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.

Pauline Corbaux, Olivier Colomban, Aurore Carrot

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Jan 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study.

Madeleine Maugeais, Julien Péron, Stéphane Dalle

|Jan 16, 2023
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis.

Pauline Corbaux, Catherine Terret, Claire Cropet

Pageof 2

Frequent Collaborators

4 joint publications

Julien Péron

2 joint publications

Thibaut Reverdy

2 joint publications

Naoual Bakrin

2 joint publications

Benoît You